MALVERN, PA, VenatoRx Pharmaceuticals, Inc., a biopharmaceutical company developing next-generation antibiotics, today announced that it has raised $42 million in a Series B financing. Read More
SAN FRANCISCO, CA, Leading provider of smart locks and smart home access products and services, today announced it raised $25 million in Series C funding. Read More
ALEXANDRIA, VA, Leading enterprise text messaging platform used by higher education institutions to improve student retention and persistence, has secured $2M in Series A funding. Read More
RADNOR, PA, Clinical stage biopharmaceutical company, today announced the completion of a $62 million Series C funding round led by New Enterprise Associates. Read More